How the big pharmas are performing
01) Up 26.8%. SNY (#06 in 2011, #10 in 2010)
02) Up 19.4%. LLY (#03 in 2011, #05 in 2010)
03) Up 18.4%. MRK (#08 in 2011, #03 in 2010)
04) Up 18.1%. PFE (#02 in 2011, #06 in 2010)
05) Up 16.5%. ABT (#04 in 2011, #09 in 2010)
06) Up 09.0%. NVS (#10 in 2011, #01 in 2010)
07) Up 07.4%. JNJ (#07 in 2011, #07 in 2010)
08) Up 04.1%. AZN (#04 in 2011, #09 in 2010)
09) Dn 05.1%. GSK (#05 in 2011, #08 in 2010)
10) Dn 07.6%. BMY (#01 in 2011, #02 in 2010)
Up 10.7%. Avg. of the ten big pharmas
Up 09.9%. Avg. of PFE's nine big peers
Up 12.1%. Avg. of the six domestic pharmas
Up 10.9%. Avg. of PFE's five domestic peers
Up 08.6%. Avg. of the four European pharmas
Up 12.7%. S & P 500 (1,258 to 1,418)
Note: In the last week, PFE moved ahead of ABT and into the #4 slot for the year. It is three dimes away from being as high as #2.
Sentiment: Buy